RankAlpha logo
Back to Rankings

ALNY

AlnylamC
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
+
Peers tracked
11
U.S. public peers
Grade Position
In line
vs peer average
ALNY vs peer average
50/100
ALNY vs. peer average (C vs. C)
Grade spread
A 2 · B 3 · C 2 · D 1 · F 3
Graded peers loaded
Coverage
11 graded
100% of tracked

Peer overview

PFE is the first available peer comparator.

Direct ATTR-CM operating comparator: Pfizer markets oral VYNDAQEL/VYNDAMAX (tafamidis), an approved ATTR-CM therapy that Alnylam identifies as a competing product. [#10-K-2026-02-12]

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerPFEPfizer
ALNY
Alnylam
PFE
Pfizer
Grade
C
B
Momentum
21
66
Value
61
65
Sentiment
66
62
Setup Bias
Net —
-
Market Cap
-
-
Posture
Mixed
Constructive
Open Side-by-Side ComparisonCompare all

Grade position vs PFE

ALNY / PFE
Grade Position
In line
ALNY vs. peer average (C vs. C)
50/100
Momentum
21
PFE
Value
61
PFE
Sentiment
66
ALNY

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs ALNY
1
PFE
PFE
B
80/100
-1
2
BBIO
BBIO
B
80/100
-1
3
IONS
IONS
A
100/100
-2
4
ZTS
Zoetis Inc Class A Common
C
60/100
Even
5
BIIB
Biogen Inc Common
C
60/100
Even
PFE is the first peer returned for this comparison set.